D-1847-2019 Class III Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- September 18, 2019
- Initiation Date
- August 27, 2019
- Termination Date
- September 9, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 60 cartons
Product Description
Lamivudine Tablets, USP, 150 mg, 30 (3x10) count Unit Dose Blisters Carton, NDC 60687-362-21 (Individual Dose NDC: 60687-362-11), Distributed by American Health Packaging, Columbus, OH
Reason for Recall
Labeling: Incorrect or Missing Package Insert; an error in the Dosage Forms and Strengths section of the insert that incorrectly lists the tablet description coding for the tablets.
Distribution Pattern
Nationwide
Code Information
Lots 186509 and 186982, exp 6/30/2021